Brief: Belgium's FSMA regulator issues warning over information from Hyloris Pharmaceuticals
July 5 (Reuters) - Hyloris Pharmaceuticals SA HYL.BR :
* Belgium's FSMA financial regulator issued a warning on
Friday
regarding the company Hyloris Pharmaceuticals HYL.BR , saying
it had doubts over the financial information issued to the
market by Hyloris.
* Reuters sent an Email and made a phone call to Hyloris,
seeking
comment from the company. There was no immediate reply.
Further company coverage: HYL.BR
(Reporting by Sudip Kar-Gupta)
((sudip.kargupta@thomsonreuters.com;))
Recent news on Hyloris Pharmaceuticals SA
See all newsEurope Research Roundup: Akzo Nobel, MTU Aero Engines, Symrise
Brief: Hyloris Pharmaceuticals Says It Obtains Exclusive License Rights In Europe & Turkey From Arbormed For Its Wilson's Disease Therapy
Brief: Hyloris Announces Partnership With Rosemont Pharmaceuticals For Atomoxetine Oral Solution In The U.S.
Brief: Hyloris Announces Positive Study Results For Dofetilide IV
Brief: Hyloris Pharmaceuticals SA Says HY 2024 Revenues (Royalties And Milestones) Increased To EUR 4,2 Million